Cited by 496Cancer survivorship and careAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesCOVID-19 and Mental Health

Anxiety Disorders in Cancer Patients: Their Nature, Associations, and Relation to Quality of Life

Stark, D., Kiely, M., Smith, A., Velikova, G., House, A., Selby, P.·2002·Journal of Clinical Oncology

Abstract

PURPOSE: We aimed to estimate the prevalence and types of anxiety disorders diagnosed according to standardized criteria in cancer patients, to compare screening tools in detecting them, and to examine their demographic, oncologic, and psychosocial associations. METHODS: In this cross-sectional observational study of 178 subjects with lymphoma, renal cell carcinoma, malignant melanoma, or plasma cell dyscrasia, we related responses to questionnaires (administered by computer touch-screen) measuring psychological symptoms, quality of life (QOL), and social support to standardized psychiatric interviews and cancer management. RESULTS: Forty-eight percent of subjects reported sufficient anxiety for anxiety disorder to be considered. At subsequent diagnostic interview, 18% fulfilled International Classification of Disorders, 10th Revision criteria for anxiety disorder, including 6% of patients who reported low levels of anxiety by questionnaire. When subjects reported anxiety by questionnaire, if disruptive somatic anxiety was present, this increased the probability of diagnosable anxiety disorder from .31 to .7. The most accurate screening questionnaires were the trait scale of the State-Trait Anxiety Inventory and the Hospital Anxiety and Depression scale. Female sex and negative aspects of social support were associated with anxiety disorder in multivariate analyses. Anxiety disorder was independently associated with a deficit in QOL, particularly insomnia. CONCLUSION: Anxiety symptoms are common in cancer patients. Screening by questionnaire seems to assess anxiety symptoms adequately but discriminates abnormal anxiety inadequately. To improve this, we may need to use criteria such as disruption from anxiety, as illustrated by the impact of anxiety disorders on QOL. There seem to be few oncologic variables that could target screening for anxiety disorders.

Integrity signals

Registry

Crossref · 10.1200/jco.2002.08.549

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stark, D., Kiely, M., Smith, A., Velikova, G., House, A., & Selby, P.
Affiliations
University of Leeds (GB)
Venue
Journal of Clinical Oncology
Published
2002-07-15
Volume
20
Issue
14
Pages
3137-3148
ISSN
  • 0732-183X (ISSN-L)
  • 1527-7755
OpenAlex
W1978479511
Cited by
496
References
41
Citations by year
2026: 11 · 2025: 11 · 2024: 10 · 2023: 13 · 2022: 14 · 2021: 13 · 2020: 21 · 2019: 20 · 2018: 14 · 2017: 27 · 2016: 23 · 2015: 28 · 2014: 44 · 2013: 28 · 2012: 26
FWCI
4.89
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
Keywords
anxiety disorders, cancer patients, quality of life, anxiety screening, State-Trait Anxiety Inventory, Hospital Anxiety and Depression Scale, somatic anxiety, social support, insomnia, lymphoma, renal cell carcinoma, melanoma, plasma cell dyscrasia, prevalence
MeSH terms
Adult, Aged, Aged, 80 and over, Analysis of Variance, Anxiety Disorders, Cross-Sectional Studies, England, Female, Humans, Male, Mass Screening, Middle Aged, Neoplasms, Quality of Life, Surveys and Questionnaires, ROC Curve, Social Support, Prevalence, Logistic Models, Area Under Curve

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review